Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
Top Cited Papers
Open Access
- 8 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 12 (1), 1-7
- https://doi.org/10.1038/s41467-021-21111-9
Abstract
There are only few data concerning persistence of neutralizing antibodies (NAbs) among SARS-CoV-2-infected healthcare workers (HCW). These individuals are particularly exposed to SARS-CoV-2 infection and at potential risk of reinfection. We followed 26 HCW with mild COVID-19 three weeks (D21), two months (M2) and three months (M3) after the onset of symptoms. All the HCW had anti-receptor binding domain (RBD) IgA at D21, decreasing to 38.5% at M3 (p < 0.0001). Concomitantly a significant decrease in NAb titers was observed between D21 and M2 (p = 0.03) and between D21 and M3 (p < 0.0001). Here, we report that SARS-CoV-2 can elicit a NAb response correlated with anti-RBD antibody levels. However, this neutralizing activity declines, and may even be lost, in association with a decrease in systemic IgA antibody levels, from two months after disease onset. This short-lasting humoral protection supports strong recommendations to maintain infection prevention and control measures in HCW, and suggests that periodic boosts of SARS-CoV-2 vaccination may be required.Funding Information
- Institut Pasteur
- Agence Nationale de la Recherche (ANR-10-LABX-77, ANR-10-LABX-62-IBEID, ANR-14-CE14-0029, ANR-14-CE14-0015-01)
- Fondation pour la Recherche Médicale
- Fondation de France
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Université Sorbonne Paris Cité
This publication has 25 references indexed in Scilit:
- Duration of serum neutralizing antibodies for SARS-CoV-2: Lessons from SARS-CoV infectionJournal of Microbiology, Immunology and Infection, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020Eurosurveillance, 2020
- Characteristics of COVID-19 infection in BeijingJournal of Infection, 2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019The New England Journal of Medicine, 2020
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Duration of Antibody Responses after Severe Acute Respiratory SyndromeEmerging Infectious Diseases, 2007
- Receptor-Binding Domain of Severe Acute Respiratory Syndrome Coronavirus Spike Protein Contains Multiple Conformation-Dependent Epitopes that Induce Highly Potent Neutralizing AntibodiesThe Journal of Immunology, 2005
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProceedings of the National Academy of Sciences of the United States of America, 2004
- The time course of the immune response to experimental coronavirus infection of manEpidemiology and Infection, 1990